Post-traumatic stress disorder and chronic fatigue syndrome-like illness among Gulf War veterans: a population-based survey of 30,000 veterans.

Veterans Health Administration, Department of Veterans Affairs, Washington, DC, USA.
American Journal of Epidemiology (Impact Factor: 4.98). 01/2003; 157(2):141-8.
Source: PubMed

ABSTRACT The authors estimated the prevalence of post-traumatic stress disorder (PTSD) and illness resembling chronic fatigue syndrome (CFS) in the entire population of Gulf War and non-Gulf-War veterans. They also evaluated the relation between the extent of deployment-related stress and the risk of either PTSD or CFS. In 1995-1997, the authors conducted a health survey in which these two symptom-based medical diagnoses in a population-based sample of 15,000 Gulf War veterans representing four military branches and three unit components (active, reserve, and National Guard) were compared with those of 15,000 non-Gulf veteran controls. Gulf War veterans, compared with non-Gulf veteran controls, reported significantly higher rates of PTSD (adjusted odds ratio = 3.1, 95% confidence interval: 2.7, 3.4) and CFS (adjusted odds ratio = 4.8, 95% confidence interval: 3.9, 5.9). The prevalence of PTSD increased monotonically across six levels of deployment-related stress intensity (test for trend: p < 0.01), while the prevalence of CFS rose only at the low end of the stress spectrum. While deployment-related stress could account for the higher risks of both PTSD and CFS, additional factor(s) unique to the Gulf environment may have contributed to the risk of CFS among Gulf War veterans.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Military combat exposure can be perceived as a great threat to the integrity of soldiers. However, no available assessment tools evaluate the degree of emotional distress that results from the exposure to various combat scenarios. This paper presents the second independent section of the Combat Exposure Questionnaire, the Combat Distress Scale (CEQ B). This questionnaire assesses Veterans' subjective emotional distress that is due to objective and typical military combat scenarios during war. Methods: A sample of 708 Portuguese Overseas War Veterans participated. The scale structure of the CEQ B was analyzed with a Rasch Model, and the internal consistency and convergent validity of the scale were studied. The temporal reliability was calculated in a subgroup of 112 participants. Two samples of war Veterans with and without war-related Post-Traumatic Stress Disorder (N = 40 and N = 47, respectively) were used to explore the scale's discriminant validity. Results: Overall, the CEQ B showed an acceptable fit to the data, excellent internal consistency, high temporal stability, adequate convergent validity and suitable discriminant validity. Limitations: This study used a population of male war Veterans that did not equally represent genders or the full adult age span, which may hinder the generalization of the results. Conclusion: The findings indicated that the CEQ B is valid, reliable and supported by convergent and discriminant data. This lends confidence in the use of the measure as an assessment of the subjective emotional distress resulting from exposure to military combat scenarios in clinical and research settings.
    Journal of Affective Disorders 01/2015; · 3.71 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Post-Traumatic Stress Disorder (PTSD) is a prevalent, disabling anxiety disorder. This prospective cohort study reports on a new exposure-based therapy known as Accelerated Resolution Therapy (ART(®)) that incorporates the use of eye movements administered in a brief treatment period (1-5 one-hour sessions within three weeks). Eighty adults aged 21-60 years with symptoms of PTSD were recruited from the Tampa Bay area. The ART-based psychotherapy was designed to minimize anxiety and body sensations associated with recall of traumatic memories and to replace distressing images with favorable ones. Participants' mean age was 40 years, 77% were female, and 29% were Hispanic. Participants underwent a median of three ART sessions, 66 of 80 (82.5%) completed treatment, and 54 of 66 (81.8%) provided 2-month follow-up data. Mean scores pre- and post-ART and at 2-month follow-up were: PTSD Checklist: 54.5 ± 12.2 vs. 31.2 ± 11.4 vs. 30.0 ± 12.4; Brief Symptom Inventory: 30.8 ± 14.6 vs. 10.1 ± 10.8 vs. 10.1 ± 12.1; Center for Epidemiologic Studies Depression Scale: 29.5 ± 10.9 vs. 11.8 ± 11.1 vs. 13.5 ± 12.1; Trauma Related Growth Inventory-Distress scale: 18.9 ± 4.1 vs. 7.4 ± 5.9 vs. 8.2 ± 5.9 (p < 0.0001 for all pre-ART vs. post-ART and 2-month comparisons). No serious adverse events were reported. ART appears to be a brief, safe, and effective treatment for symptoms of PTSD.
    Behavioral sciences (Basel, Switzerland). 06/2012; 2(2):115-34.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Deployed soldiers are at risk of developing stress-related conditions, including posttraumatic stress disorder (PTSD), major depressive disorder (MDD), and severe fatigue. We previously observed condition- and cell-specific differences in sensitivity of immune cells for regulation by glucocorticoids (GCs) pre-deployment between male soldiers with and without subsequent development of high levels of these stress-related symptoms. Here we investigated whether these pre-deployment dysregulations in GC-sensitivity of immune cells persisted after return from military deployment. In a prospective, longitudinal study including 721 male and female soldiers, the in vitro GC-sensitivity of monocytes and T-cells was assessed prior to deployment and one and six months post-deployment. Differences in the longitudinal course of sensitivity for regulation by dexamethasone (DEX) of LPS-stimulated TNF-α production and PHA-stimulated T-cell proliferation between soldiers with and without subsequent symptom development were investigated using linear mixed models. Within the whole group, DEX-sensitivity of monocytes was significantly decreased at six months post-deployment compared to the assessments pre-deployment and one month post-deployment. The DEX-sensitivity of T-cells did not significantly change over time. Participants developing high levels of PTSD symptoms showed high DEX-sensitivity of T-cells, while participants developing high levels of depressive symptoms showed low DEX-sensitivity of T-cells before deployment that persisted at the two time points after return. In addition, participants developing severe fatigue had low DEX-sensitivity of monocytes at all assessments. Our finding that the previously observed pre-deployment group differences in peripheral GC-sensitivity persisted until at least six months after return indicates that in vitro GC-sensitivity of T-cells and monocytes may represent a persistent biological vulnerability factor for development of stress-related conditions PTSD, depression and fatigue.
    Psychoneuroendocrinology 09/2014; · 5.59 Impact Factor

Full-text (2 Sources)

Available from
May 31, 2014